Table of Content


1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Total Artificial Heart Overview

3 Products under Development
3.1 Total Artificial Heart - Pipeline Products by Stage of Development
3.2 Total Artificial Heart - Pipeline Products by Territory
3.3 Total Artificial Heart - Pipeline Products by Regulatory Path
3.4 Total Artificial Heart - Pipeline Products by Estimated Approval Date
3.5 Total Artificial Heart - Ongoing Clinical Trials

4 Total Artificial Heart - Pipeline Products under Development by Companies
4.1 Total Artificial Heart Companies - Pipeline Products by Stage of Development
4.2 Total Artificial Heart - Pipeline Products by Stage of Development

5 Total Artificial Heart Companies and Product Overview
5.1 Abiomed Inc Company Overview
5.1.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 BiVacor Pty Ltd Company Overview
5.2.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Carmat SAS Company Overview
5.3.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cleveland Clinic Lerner College of Medicine Company Overview
5.4.1 Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cleveland Heart Inc Company Overview
5.5.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Foster-Miller Inc (Ictive) Company Overview
5.6.1 Foster-Miller Inc (Ictive) Pipeline Products & Ongoing Clinical Trials Overview
5.7 Indian Institute of Technology Kharagpur Company Overview
5.7.1 Indian Institute of Technology Kharagpur Pipeline Products & Ongoing Clinical Trials Overview
5.8 Lausanne University Hospital Company Overview
5.8.1 Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.9 OregonHeart Inc (Ictive) Company Overview
5.9.1 OregonHeart Inc (Ictive) Pipeline Products & Ongoing Clinical Trials Overview
5.10 ReliantHeart, Inc. Company Overview
5.10.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Scandivian Real Heart AB Company Overview
5.11.1 Scandivian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview
5.12 Syncardia Systems LLC Company Overview
5.12.1 Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview
5.13 TEDA Intertiol Cardiovascular Hospital Company Overview
5.13.1 TEDA Intertiol Cardiovascular Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.14 University of Tokyo Company Overview
5.14.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview
5.15 Yale University Company Overview
5.15.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview

6 Total Artificial Heart- Recent Developments

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer



List of Figures



Figure 1: Total Artificial Heart - Pipeline Products by Stage of Development
Figure 2: Total Artificial Heart - Pipeline Products by Territory
Figure 3: Total Artificial Heart - Pipeline Products by Regulatory Path
Figure 4: Total Artificial Heart - Pipeline Products by Estimated Approval Date
Figure 5: Total Artificial Heart - Ongoing Clinical Trials


List of Tables



Table 1: Total Artificial Heart - Pipeline Products by Stage of Development
Table 2: Total Artificial Heart - Pipeline Products by Territory
Table 3: Total Artificial Heart - Pipeline Products by Regulatory Path
Table 4: Total Artificial Heart - Pipeline Products by Estimated Approval Date
Table 5: Total Artificial Heart - Ongoing Clinical Trials
Table 6: Total Artificial Heart Companies - Pipeline Products by Stage of Development
Table 7: Total Artificial Heart - Pipeline Products by Stage of Development
Table 8: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview